DE3423105A1 - METHOD FOR PRODUCING OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE - Google Patents
METHOD FOR PRODUCING OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINEInfo
- Publication number
- DE3423105A1 DE3423105A1 DE19843423105 DE3423105A DE3423105A1 DE 3423105 A1 DE3423105 A1 DE 3423105A1 DE 19843423105 DE19843423105 DE 19843423105 DE 3423105 A DE3423105 A DE 3423105A DE 3423105 A1 DE3423105 A1 DE 3423105A1
- Authority
- DE
- Germany
- Prior art keywords
- carbon atoms
- radical
- alkyl
- phenyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 16
- -1 pyrryl Chemical group 0.000 claims description 64
- 125000004432 carbon atom Chemical group C* 0.000 claims description 50
- 125000000217 alkyl group Chemical group 0.000 claims description 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 21
- 125000003277 amino group Chemical group 0.000 claims description 15
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 15
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- 150000002367 halogens Chemical class 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 10
- 229910052731 fluorine Inorganic materials 0.000 claims description 10
- 239000011737 fluorine Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- 125000004076 pyridyl group Chemical group 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 239000000460 chlorine Substances 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 8
- 150000003254 radicals Chemical class 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 150000005840 aryl radicals Chemical class 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 5
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 5
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 5
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 5
- 125000002541 furyl group Chemical group 0.000 claims description 5
- 125000005842 heteroatom Chemical group 0.000 claims description 5
- 125000002883 imidazolyl group Chemical group 0.000 claims description 5
- 125000001041 indolyl group Chemical group 0.000 claims description 5
- 125000005956 isoquinolyl group Chemical group 0.000 claims description 5
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 125000002971 oxazolyl group Chemical group 0.000 claims description 5
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 5
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 5
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 5
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 5
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 5
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims description 5
- 125000005493 quinolyl group Chemical group 0.000 claims description 5
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- 239000011593 sulfur Substances 0.000 claims description 5
- 125000004434 sulfur atom Chemical group 0.000 claims description 5
- 125000000335 thiazolyl group Chemical group 0.000 claims description 5
- 125000001544 thienyl group Chemical group 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 150000007857 hydrazones Chemical class 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 4
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 claims description 3
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 3
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 3
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 3
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
- 150000001805 chlorine compounds Chemical class 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- NQNOMXXYKHWVKR-UHFFFAOYSA-N methylazanium;sulfate Chemical class NC.NC.OS(O)(=O)=O NQNOMXXYKHWVKR-UHFFFAOYSA-N 0.000 claims description 2
- 150000003891 oxalate salts Chemical class 0.000 claims description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 claims 1
- 101150052863 THY1 gene Proteins 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 150000002430 hydrocarbons Chemical group 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- DVTISYCASHXMIQ-UHFFFAOYSA-N 2,6-dimethyl-5-(3-methylbutoxycarbonyl)-4-(2-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid Chemical compound C(C(C)C)COC(=O)C1=C(NC(=C(C1C1=C(C=CC=C1)[N+](=O)[O-])C(=O)O)C)C DVTISYCASHXMIQ-UHFFFAOYSA-N 0.000 description 2
- YDHSGGOMIVKVJX-UHFFFAOYSA-N 3-O-methyl 5-O-propan-2-yl pyridine-3,5-dicarboxylate Chemical compound C(C)(C)OC(=O)C=1C=C(C=NC1)C(=O)OC YDHSGGOMIVKVJX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- VCANFPCGJANMAK-UHFFFAOYSA-N 1,2,6-trimethyl-4-(2-nitrophenyl)-4h-pyridine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=C(C)N(C)C(C)=C(C(O)=O)C1C1=CC=CC=C1[N+]([O-])=O VCANFPCGJANMAK-UHFFFAOYSA-N 0.000 description 1
- SYHPGXUWPYJXOO-UHFFFAOYSA-N 1,4-dihydropyridine-2,3-dicarboxylic acid Chemical class OC(=O)C1=C(C(O)=O)NC=CC1 SYHPGXUWPYJXOO-UHFFFAOYSA-N 0.000 description 1
- COLPLFZHPXIFCQ-UHFFFAOYSA-N 1,4-dihydropyridine-3,5-dicarboxylic acid Chemical class OC(=O)C1=CNC=C(C(O)=O)C1 COLPLFZHPXIFCQ-UHFFFAOYSA-N 0.000 description 1
- RMZQSAMHIQBMLW-UHFFFAOYSA-N 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC=C1[N+]([O-])=O RMZQSAMHIQBMLW-UHFFFAOYSA-N 0.000 description 1
- NCHLDZALJLMLPJ-UHFFFAOYSA-N 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine Chemical compound C1=C(C)NC(C)=CC1C1=CC=CC([N+]([O-])=O)=C1 NCHLDZALJLMLPJ-UHFFFAOYSA-N 0.000 description 1
- TZDPJNSHSWMCPN-UHFFFAOYSA-N 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 TZDPJNSHSWMCPN-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- DSZWJKBNTMVXEO-UHFFFAOYSA-N 3-o-ethyl 5-o-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 DSZWJKBNTMVXEO-UHFFFAOYSA-N 0.000 description 1
- XBNFAKYRYKBSAO-UHFFFAOYSA-N 3-o-methyl 5-o-(2,2,2-trifluoroethyl) 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(F)(F)F)C1C1=CC=CC=C1Cl XBNFAKYRYKBSAO-UHFFFAOYSA-N 0.000 description 1
- LOODEFRHSUINOX-UHFFFAOYSA-N 3-o-methyl 5-o-(2-phenoxyethyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCOC=2C=CC=CC=2)C1C1=CC=CC=C1[N+]([O-])=O LOODEFRHSUINOX-UHFFFAOYSA-N 0.000 description 1
- UFBVEBSZOZXYBE-UHFFFAOYSA-N 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC=C1Cl UFBVEBSZOZXYBE-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- RZTAMFZIAATZDJ-UHFFFAOYSA-N felodipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-UHFFFAOYSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- MRSJBSHLMOBYSH-UHFFFAOYSA-N m-Nisoldipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 MRSJBSHLMOBYSH-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- UIAGMCDKSXEBJQ-UHFFFAOYSA-N nimodipine Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-UHFFFAOYSA-N 0.000 description 1
- PVHUJELLJLJGLN-UHFFFAOYSA-N nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
BAYER AKTIENGESELLSCHAFT 5090 Leverkusen, BayerwerkBAYER AKTIENGESELLSCHAFT 5090 Leverkusen, Bayerwerk
Konzernverwaltung RP KS/by-c «η 1MiYl Patentabteilung IV (Pha) c υ" '''Group administration RP KS / by-c «η 1 MiYl Patent Department IV (Pha) c υ "'''
Verfahren zur Herstellung optisch aktiver 1,4-Dihydropyridine Process for the preparation of optically active 1,4-dihydropyridines
Die vorliegende Erfindung betrifft ein neuartiges Verfahren zur Herstellung optisch aktiver 1,4-Dihydropyridin-Derivate. The present invention relates to a novel process for the preparation of optically active 1,4-dihydropyridine derivatives.
Es ist bereits bekannt geworden, daß bestimmte 1,4-Dihydropyridin-Derivate interessante pharmakologische Eigenschaften aufweisen und insbesondere als kreislaufbeeinflussende Mittel verwendet werden (vgl. F. Bossert und W. Vater, Naturwissenschaften 5jJ, 578 (1971) und DE-OS 21 17 571).It is already known that certain 1,4-dihydropyridine derivatives have interesting pharmacological properties and in particular as influencing the circulation Funds are used (see F. Bossert and W. Vater, Naturwissenschaften 5jJ, 578 (1971) and DE-OS 21 17 571).
Weiterhin ist bereits bekannt, daß die Antipoden chiraler 1,4-Dihydropyridin-3,5-dicarbonsäureester nach verschiedenen Verfahren dargestellt werden können (DE-OS 29 35 451; T. Shibanuma et al. Chem. Pharm. Bull. 28., 2809 (1980); DE-OS 33 20 616).Furthermore, it is already known that the antipodes are chiral 1,4-dihydropyridine-3,5-dicarboxylic acid esters can be represented by various methods (DE-OS 29 35 451; T. Shibanuma et al. Chem. Pharm. Bull. 28., 2809 (1980); DE-OS 33 20 616).
Gegenstand der vorliegenden Erfindung ist ein neues, chemisch eigenartiges Verfahren zur Darstellung derThe present invention is a new, chemically peculiar process for the preparation of
Le A 23 151Le A 23 151
2T-2T-
■43-■ 43-
optischen Antipoden chiraler 1,4-Dihydropyridin-3,5· dicarbonsäurediester.optical antipodes of chiral 1,4-dihydropyridine-3,5 dicarboxylic acid diester.
Es wurde gefunden, daß man die teilweise bekannten Antipoden chiraler 1,4-Dihydropyridin-dicarbonsäureester der allgemeinen Formel (I),It has been found that the partially known antipodes of chiral 1,4-dihydropyridine dicarboxylic acid esters can be used of the general formula (I),
(D(D
in welcherin which
R für carbocyclisches Aryl oder für Heterocyclen aus der Gruppe Thienyl, Furyl, Pyrryl, Pyrazolyl, Imidazolyl, Oxazolyl, Isoxazolyl, Thiazolyl, Pyridyl, Pyridazinyl, Pyrimidyl, Pyrazinyl, Indolyl, Benzimidazolyl, Benzoxazolyl, Benzoxadiazolyl, Benzthiadiazolyl, Chinolyl, Isochinolyl, Chinazolyl oder Chinoxalyl steht, wobei der Arylrest sowie die Heterocyclen gegebenenfalls 1 bis 3 gleiche oder verschiedene Substituenten aus der Gruppe Phenyl, Alkyl, Alkoxy, Alkylen, Dioxyalkylen, Halogen, Polyfluoralkyl, Polyfluoralkoxy, Alkylamino, Nitro, Cyano, Azido, Alkoxycarbonyl oder SO -Alkyl (m = 0 bis 2) enthalten,R for carbocyclic aryl or for heterocycles from the group consisting of thienyl, furyl, pyrryl, pyrazolyl, Imidazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidyl, pyrazinyl, Indolyl, benzimidazolyl, benzoxazolyl, benzoxadiazolyl, benzthiadiazolyl, quinolyl, isoquinolyl, Quinazolyl or quinoxalyl, the aryl radical and the heterocycles optionally 1 to 3 identical or different substituents from the group phenyl, alkyl, alkoxy, alkylene, dioxyalkylene, Halogen, polyfluoroalkyl, polyfluoroalkoxy, Contain alkylamino, nitro, cyano, azido, alkoxycarbonyl or SO -alkyl (m = 0 to 2),
R und R immer verschieden sind und für einen achiralen geradkettigen, verzweigten oder cyclischen, gesättigten oder ungesättigten Kohlenwasserstoff-R and R are always different and represent an achiral straight-chain, branched or cyclic, saturated one or unsaturated hydrocarbon
Le A 23 151Le A 23 151
rest stehen, der gegebenenfalls durch ein Sauerstoff- oder Schwefelatom in der Kette unterbrochen ist, und/oder der gegebenenfalls substituiert ist durch Halogen, Cyano, Alkoxycarbonyl, Phenyl, Phenoxy, Phenylthio oder Phenylsulfonyl wobei die Phenylgruppen ihrerseits substituiert sein können durch Halogen, Cyano, Dialkylamino, Alkoxy, Alkyl, Trifluormethyl oder Nitro, oder wobei der Kohlenwasserstoffrest substituiert sein kann durch Pyridyl oder eine Aminogruppe, wobei diese Aminogruppe durch zwei gleiche oder verschiedene Substituenten aus der Gruppe Alkyl, Alkoxyalkyl, Aryl oder Aralkyl substituiert ist, oder wobei die Aminogruppe in der Weise substituiert ist, daß zwei Substituenten gemeinsam mit dem Stickstoffatom einen 5- bis 7-gliedrigen Ring bilden, der als weiteres Heteroatom Sauerstoff oder Schwefel oder eine N-Alkyl/Phenyl-Gruppierung enthalten kann,remaining, which may be replaced by an oxygen or sulfur atom in the chain is interrupted, and / or which is optionally substituted is represented by halogen, cyano, alkoxycarbonyl, phenyl, phenoxy, phenylthio or phenylsulfonyl where the phenyl groups in turn can be substituted by halogen, cyano, dialkylamino, Alkoxy, alkyl, trifluoromethyl or nitro, or where the hydrocarbon radical is substituted can be by pyridyl or an amino group, this amino group by two identical or various substituents from the group consisting of alkyl, alkoxyalkyl, aryl or aralkyl is substituted, or wherein the amino group is substituted in such a way that two substituents together with the nitrogen atom form a 5- to 7-membered ring, the other heteroatom is oxygen or sulfur or an N-alkyl / phenyl group may contain
44th
R und R gleich oder verschieden sein können und jeweils für Wasserstoff, einen achiralen geradkettigen oder verzweigten, gegebenenfalls substituierten Alkylrest, einen Arylrest oder einen Aralkylrest stehenR and R can be identical or different and each represents hydrogen, an achiral straight-chain or branched, optionally substituted alkyl radical, an aryl radical or a Aralkyl radical
undand
R für Wasserstoff oder einen achiralen geradkettigen oder verzweigten Alkylrest, einen Arylrest oderR represents hydrogen or an achiral straight-chain or branched alkyl radical, an aryl radical or
Le A 23 151Le A 23 151
einen Aralkylrest steht,represents an aralkyl radical,
erhält, wenn man die Verbindungen der allgemeinen Formel (II) (einschließlich ihrer prototropen Formen)obtained when the compounds of the general formula (II) (including their prototropic forms)
r102Cv^\^C02R5 R2 NR4 r1 0 2 Cv ^ \ ^ C0 2 R 5 R 2 NR 4
R3R3
1111
12 4 512 4 5
in welcher die Reste R, R , R , R und R die oben angegebene Bedeutung haben und R für einen Alkyl oder Aralkylrest steht und in welcher die Konfiguration an den mit (*) bezeichneten Kohlenstoffatomen einheitlich definiert ist,in which the radicals R, R, R, R and R have the meaning given above and R is an alkyl or aralkyl radical and in which the configuration at the carbon atoms marked with (*) is uniformly defined is,
mit Aminen der allgemeinen Formel (III)with amines of the general formula (III)
R3-NH2 (III)R 3 -NH 2 (III)
bzw. deren Säureadditionssalzen,
in welchen R die oben angegebene Bedeutung hat,or their acid addition salts,
in which R has the meaning given above,
gegebenenfalls in Gegenwart geeigneter Lösungsmittel zur Reaktion bringt.optionally reacting in the presence of suitable solvents.
Le A 23 151Le A 23 151
Ein wesentlicher Vorteil des Verfahrens liegt darin, daß es aufgrund seiner einfachen Reaktionsbedingungen mit geringem technischen Aufwand und hoher Wirtschaftlichkeit durchgeführt werden kann, wobei besonders darauf hinzuweisen ist, daß bei der Umsetzung (S)- bzw. (R) -1 -Amino-2-alk (aralk)oxymethyl-pyrrolidin wieder freigesetzt wird und erneut als chiraler Induktor in den Reaktionsprozeß eingebracht werden kann.A major advantage of the process is that it is due to its simple reaction conditions can be carried out with little technical effort and high economic efficiency, with particular It should be pointed out that in the reaction (S) - or (R) -1-amino-2-alk (aralk) oxymethyl-pyrrolidine is released again and can be reintroduced into the reaction process as a chiral inductor.
Die Darstellung eines optisch aktiven 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure- ethyl-isopropyl-esters kann beispielhaft durch folgendes Formelschema wiedergegeben werden:The preparation of an optically active 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) -pyridine-3,5-dicarboxylic acid Ethyl isopropyl ester can be exemplified by the following Formula scheme can be reproduced:
O2C ^k CO2C2H5 O 2 C ^ k CO 2 C 2 H 5
N CH3 HN CH3 H
Nach dem erfindungsgemäßen Verfahren erhält man ein optisch aktives 1,4-Dihydropyridin-Derivat der allgemeinen Formel (I) durch Umsetzung eines optisch aktiven, einheitlich konfigurierten Hydrazons der allge-The process according to the invention gives an optically active 1,4-dihydropyridine derivative of the general type Formula (I) by reaction of an optically active, uniformly configured hydrazone of the general
Le A 23 151Le A 23 151
meinen Formel (II) mit einem Amin bzw. dessen Säureadditionssalz der allgemeinen Formel (III) gegebenenfalls in Gegenwart eines geeigneten Lösungsmittels.mean formula (II) with an amine or its acid addition salt of the general formula (III), if appropriate in the presence of a suitable solvent.
In den Formeln (I) und (II) steht vorzugsweiseIn the formulas (I) and (II) preferably stands
R für einen Phenyl- oder Naphthylrest oder für Thienyl, Furyl, Pyrryl, Pyrazolyl, Imidazolyl, Oxazolyl/ Isoxazolyl, Thiazolyl, Pyridyl, Pyridazinyl, Pyrimidyl, Pyrazinyl, Indolyl, Benzimidazolyl, Benzoxazolyl, Benzisoxazolyl, Benzoxadiazolyl, Benzthiadiazolyl, Chinolyl, Isochinolyl, Chinazolyl oder Chinoxalyl, wobei die genannten Heterocyclen sowie der Phenylrest und der Naphthylrest 1 bis 3 gleiche oder verschiedene Substituenten tragen können, wobei als Substituenten Phenyl, geradkettiges oder verzweigtes Alkyl mit bis zu 8 Kohlenstoffatomen, Cycloalkyl mit 3 bis 7 Kohlenstoffatomen, Alkenyl oder Alkinyl mit 2 bis 6 Kohlenstoffatomen, Alkoxy mit 1 bis 4 Kohlenstoffatomen, Alkenoxy und Alkinoxy mit 2 bis 6 Kohlenstoffatomen, Tri-, Tetra- und Pentamethylen, Dioxymethylen, Dioxyethyliden, Halogen wie Fluor, Chlor, Brom oder Jod, Trifluormethyl, Trifluorethyl, Trifluormethoxy, Difluormethoxy, Tetrafluorethoxy, Dialkylamino mit 1 bis 4 C-Atomen, Nitro, Cyano, Azido, Alkoxycarbonyl mit 1 bis C-Atomen im Alkoxyrest oder SO -Alkyl, worin m 0 oder 2 bedeutet und Alkyl 1 bis 4 Kohlenstoffatome enthält, aufgeführt seien.R stands for a phenyl or naphthyl radical or for thienyl, furyl, pyrryl, pyrazolyl, imidazolyl, Oxazolyl / isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidyl, pyrazinyl, indolyl, Benzimidazolyl, Benzoxazolyl, Benzisoxazolyl, Benzoxadiazolyl, Benzthiadiazolyl, Quinolyl, Isoquinolyl, quinazolyl or quinoxalyl, the said heterocycles and the phenyl radical and the naphthyl radical 1 to 3 can carry identical or different substituents, where as Substituents phenyl, straight-chain or branched alkyl with up to 8 carbon atoms, Cycloalkyl with 3 to 7 carbon atoms, alkenyl or alkynyl with 2 to 6 carbon atoms, Alkoxy with 1 to 4 carbon atoms, alkenoxy and alkynoxy with 2 to 6 carbon atoms, Tri-, tetra- and pentamethylene, dioxymethylene, dioxyethylidene, halogen such as fluorine, Chlorine, bromine or iodine, trifluoromethyl, trifluoroethyl, Trifluoromethoxy, difluoromethoxy, tetrafluoroethoxy, Dialkylamino with 1 to 4 carbon atoms, nitro, cyano, azido, alkoxycarbonyl with 1 to C atoms in the alkoxy radical or SO -alkyl, in which m is 0 or 2 and alkyl is 1 to 4 carbon atoms contains.
Le A 23 151Le A 23 151
•AS-• AS-
Weiterhin stehen in den Formeln (I) und (II) vorzugsweise Furthermore, in the formulas (I) and (II) are preferred
5
R und R , die immer verschieden sind, für einen achiralen geradkettigen, verzweigten oder cyclisehen,
gesättigten oder ungesättigten Kohlenwasserstoff rest mit bis zu 8 Kohlenstoffatomen,
der gegebenenfalls durch ein Sauerstoff- oder Schwefelatom in der Kette unterbrochen ist und/
oder der gegebenenfalls substituiert ist durch Halogen wie Fluor oder Chlor, Cyano, Alkoxycarbonyl
mit bis zu 4 Kohlenstoffatomen im Alkylteil,
Phenyl, Phenoxy, Phenylthio oder Phenylsulfonyl, wobei die Phenylgruppen ihrerseits
substituiert sein können durch Halogen wie Fluor oder Chlor, Cyano, Dialkylamino mit bis zu 4
Kohlenstoffatomen je Alkylgruppe, Alkoxy oder Alkyl mit jeweils bis zu 4 Kohlenstoffatomen,
Trifluormethyl oder Nitro, oder wobei der Kohlenwasserstoffrest
substituiert sein kann durch Pyridyl oder eine Aminogruppe, wobei diese Aminogruppe
durch zwei gleiche oder verschiedene Substituenten aus der Gruppe Alkyl mit bis zu 4 Kohlenstoffatomen,
Alkoxyalkyl mit bis zu 6 Kohlenstoffatomen, Aryl, insbesondere Phenyl, oder Aralkyl,
insbesondere Benzyl, substituiert ist, oder wobei die Aminogruppe in der Weise substituiert ist,
daß zwei Reste gemeinsam mit dem Stickstoffatom einen 5- bis 7-gliedrigen heterocyclischen Ring
bilden, der als weiteres Heteroatom Sauerstoff5
R and R, which are always different, represent an achiral straight-chain, branched or cyclic, saturated or unsaturated hydrocarbon radical with up to 8 carbon atoms, which is optionally interrupted by an oxygen or sulfur atom in the chain and / or which is optionally substituted by Halogen such as fluorine or chlorine, cyano, alkoxycarbonyl with up to 4 carbon atoms in the alkyl part, phenyl, phenoxy, phenylthio or phenylsulfonyl, whereby the phenyl groups in turn can be substituted by halogen such as fluorine or chlorine, cyano, dialkylamino with up to 4 carbon atoms per alkyl group, Alkoxy or alkyl, each with up to 4 carbon atoms, trifluoromethyl or nitro, or where the hydrocarbon radical can be substituted by pyridyl or an amino group, this amino group being replaced by two identical or different substituents from the group consisting of alkyl with up to 4 carbon atoms, alkoxyalkyl with up to 6 carbon atoms, aryl, in especially phenyl, or aralkyl, especially benzyl, is substituted, or where the amino group is substituted in such a way that two radicals together with the nitrogen atom form a 5- to 7-membered heterocyclic ring, the further heteroatom is oxygen
Le A 2 3 151Le A 2 3 151
A9-A9-
oder Schwefel oder eine N-Alkyl/Phenyl-Gruppierung enthalten kann,or sulfur or an N-alkyl / phenyl group may contain
undand
2 4
R und R , gleich oder verschieden sein können, für Wasserstoff oder vorzugsweise für einen geradkettigen
oder verzweigten, gegebenenfalls substituierten Alkylrest mit bis zu 4 Kohlenstoffatomen,
einen Phenyl oder einen Benzylrest. 2 4
R and R, which can be identical or different, represent hydrogen or, preferably, a straight-chain or branched, optionally substituted alkyl radical with up to 4 carbon atoms, a phenyl or a benzyl radical.
Weiterhin steht in der Formel II R vorzugsweise für einen achiralen geradkettigen oder verzweigten Alkylrest mit bis zu 4 Kohlenstoffatomen, insbesondere für die Methylgruppe, oder für einen Aralkylrest, insbesondere für den Benzylrest.Furthermore, in formula II, R preferably represents an achiral straight-chain or branched alkyl radical with up to 4 carbon atoms, in particular for the methyl group, or for an aralkyl radical, in particular for the benzyl radical.
Die Verbindungen der allgemeinen Formel (II) sind neu und können in Analogie zu literaturbekannten Verfahren durch Addition eines optisch aktiven Hydrazons des (S)- bzw. (R)-1-Amino-2-alk(aralk)oxymethyl-pyrrolidins der allgemeinen Formel (IV) einschließlich seiner prototropen Formen an stereochemisch einheitlicheThe compounds of the general formula (II) are new and can, in analogy to processes known from the literature, by addition of an optically active hydrazone of the (S) - or (R) -1-amino-2-alk (aralk) oxymethyl-pyrrolidines of the general formula (IV) including its prototropic forms to stereochemically uniform
.CO2R1 .CO 2 R 1
R-CH=C - R4-C-CH2-CO2R5 R-CH = C-R 4 -C-CH 2 -CO 2 R 5
NCOR2 " N COR 2 "
N VN V
OR6 OR 6
Le A 23 151Le A 23 151
prochirale Yliden-ß-ketocarbonsäureester der allgemeinen Formel (V) erhalten werden (vgl. D. Enders und K. Papdopoulos, Tetrahedron Letters 24' 4967 (1983)). In den Formeln (IV) und (V) haben die Reste R, R , R , R , R und R die oben angegebene Bedeutung.prochiral ylidene-ß-ketocarboxylic acid esters of the general Formula (V) can be obtained (cf. D. Enders and K. Papdopoulos, Tetrahedron Letters 24 '4967 (1983)). In the formulas (IV) and (V) the radicals R, R, R, R, R and R have the meanings given above.
In den Formeln (I) und (III) stehtIn the formulas (I) and (III) stands
R vorzugsweise für Wasserstoff oder einen achiralen geradkettigen oder verzweigten Alkylrest mit bis zu 4 Kohlenstoffatomen/ einen Phenylrest oder einen Benzylrest.R preferably represents hydrogen or an achiral straight-chain or branched alkyl radical with up to to 4 carbon atoms / a phenyl radical or a benzyl radical.
Die als Ausgangsverbindungen eingesetzten Amine der Formel (III) bzw. deren Säureadditionssalze sind bekannt. Als Säureadditionssalze kommen die Salze sowohl von anorganischen als auch von organischen Säuren in Frage, wobei Halogenwasserstoffsäuren, Schwefelsäure, Kohlensäure und Essigsäure beispielhaft genannt seien.The amines of the formula (III) or their acid addition salts used as starting compounds are known. As acid addition salts, the salts come from both inorganic and organic acids in question, whereby hydrohalic acids, sulfuric acid, Carbonic acid and acetic acid may be mentioned by way of example.
Insbesondere seien genannt Ammonium- und Methylammonium-Sulfate, Chloride, Carbonate, Hydrogencarbonate, Acetate und Oxalate.Ammonium and methylammonium sulfates, chlorides, carbonates, hydrogen carbonates and acetates may be mentioned in particular and oxalates.
Als Verdünnungsmittel können alle inerten organischen Lösungsmittel Verwendung finden. Hierzu gehören vorzugsweise Alkohole wie Methanol oder Ethanol, Ether wie Tetrahydrofuran, Glykolmonomethylether oder Glykoldimethylether, Eisessig, Dimethylformamid, Dimethylsulfoxid, Acetonitril, Pyridin oder Hexamethylphosphorsäuretriamid. All inert organic solvents can be used as diluents. These preferably include Alcohols such as methanol or ethanol, ethers such as tetrahydrofuran, glycol monomethyl ether or Glycol dimethyl ether, glacial acetic acid, dimethylformamide, dimethyl sulfoxide, acetonitrile, pyridine or hexamethylphosphoric acid triamide.
Le A 23 151Le A 23 151
Die Reaktionstemperaturen können in einem größeren Bereich variiert werden. Im allgemeinen arbeitet man zwischen 0 und 1500C, vorzugsweise zwischen 20 und 1000C, insbesondere bei Siedetemperatur des jeweiligen Lösungsmittels.The reaction temperatures can be varied over a wide range. In general, the temperature is between 0 and 150 ° C., preferably between 20 and 100 ° C., in particular at the boiling point of the particular solvent.
Die Umsetzung kann bei Normaldruck, aber auch bei erhöhtem Druck durchgeführt werden. Im allgemeinen arbeitet man unter Normaldruck.The reaction can be carried out under normal pressure, but also under increased pressure. Generally works one under normal pressure.
Bei der Durchführung des erfindungsgemäßen Verfahrens wird 1 Mol des Hydrazons der allgemeinen Formel (II) mit 1 bis 5 Mol des Amins der allgemeinen Formel (III) bzw. dessen Säureadditionssalzes in einem geeigneten Lösungsmittel zur Reaktion gebracht.When carrying out the method according to the invention 1 mole of the hydrazone of the general formula (II) with 1 to 5 moles of the amine of the general formula (III) or its acid addition salt reacted in a suitable solvent.
Die Isolierung und Reinigung der Endprodukte erfolgt vorzugsweise derart, daß man das Lösungsmittel im Vakuum abdestilliert und den Rückstand gegebenenfalls den aus dem Stand der Technik her bekannten Reinigungsoperationen wie der Umkristallisation aus einem geeigneten Lösungsmittel oder der chromatographischen Trennung unterwirft.The isolation and purification of the end products is preferably carried out in such a way that the solvent in Distilled off in vacuo and the residue, if appropriate, the purification operations known from the prior art, such as recrystallization from a suitable one Solvent or subjected to chromatographic separation.
Das erfindungsgemäße Verfahren eignet sich zur Darstellung der optischen Antipoden chiraler 1,4-Dihydropyridin-3,5-dicarbonsäurediester mit einem breiten Spektrum von Substituenten und Strukturvariationen.The method according to the invention is suitable for representation of the optical antipodes of chiral 1,4-dihydropyridine-3,5-dicarboxylic acid diesters with a wide range of substituents and structural variations.
Außer den unten angeführten Herstellungsbeispielen seien die Enantiomere folgender Wirkstoffe besonders erwähnt:In addition to the preparation examples given below, the enantiomers of the following active ingredients are special mentioned:
Le A 23 151Le A 23 151
1,4-Dihydro-2,6-dimethyl-4-{3-nitrophenyl)-pyridin-3,5-dicarbonsäure-isobutyl-methyl-ester, 1,4-dihydro-2,6-dimethyl-4- {3-nitrophenyl) pyridine-3,5-dicarboxylic acid isobutyl methyl ester,
1,4-Dihydro-2,6~dimethyl-4-(3-nitrophenyl)-pyridin-3,S-dicarbonsäure-methyl-neopentylester, 1,4-Dihydro-2,6 ~ dimethyl-4- (3-nitrophenyl) -pyridine-3, S-dicarboxylic acid methyl neopentyl ester,
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,S-dicarbonsäure-cyclopentyl-methyl-ester, 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) pyridine-3, S-dicarboxylic acid cyclopentyl methyl ester,
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure-isopropyl-(2-methoxyethyl)-ester, 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) pyridine-3,5-dicarboxylic acid isopropyl (2-methoxyethyl) ester,
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure-methy1-(2-N-benzyl-N-methylamino- ethyl)-ester, 1, 4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) -pyridine-3,5-dicarboxylic acid-methy1- (2-N-benzyl-N-methylamino-ethyl) ester,
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure-methyl-(2-(4-phenyl-piperazinyl-1)-ethyl)-ester, 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) pyridine-3,5-dicarboxylic acid methyl (2- (4-phenyl-piperazinyl-1) ethyl) ester,
1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-pyridin-3,5-dicarbonsäure-benzy1-methyl-ester, 1,4-dihydro-2,6-dimethyl-4- (2-nitrophenyl) -pyridine-3,5-dicarboxylic acid-benzy1-methyl-ester,
1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-pyridin-3,5-dicarbonsäure-methyl-(2-phenoxyethy1)-ester, 1,4-dihydro-2,6-dimethyl-4- (2-nitrophenyl) pyridine-3,5-dicarboxylic acid methyl (2-phenoxyethyl) ester,
1,4-Dihydro-2,6-dimethyl-4-(2-trifluormethylpheny1)-pyridin-3,5-dicarbonsäure-isopropyl-methyl-ester, 1,4-dihydro-2,6-dimethyl-4- (2-trifluoromethylpheny1) -pyridine-3,5-dicarboxylic acid isopropyl methyl ester,
1,4-Dihydro-2,6-dimethyl-4-{2-chlorphenyl)-pyridin-3,5-dicarbonsäure-allyl-inethyl-ester, 1,4-Dihydro-2,6-dimethyl-4- {2-chlorophenyl) -pyridine-3,5-dicarboxylic acid-allyl-methyl-ester,
Le A 23 151Le A 23 151
1,4-Dihydro-2,6-dimethyl-4-(2,3-dichlorphenyl)-pyridin-3,5-dicarbonsäure-ethyl-methyl-ester, 1,4-dihydro-2,6-dimethyl-4- (2,3-dichlorophenyl) -pyridine-3,5-dicarboxylic acid ethyl methyl ester,
1^-Di1 ^ -Di
3,5-dicarbonsäure-hexyl-methyl-ester,3,5-dicarboxylic acid hexyl methyl ester,
1,4-Dihydro-2,6-dimethyl-4-(2-chlorphenyl)-pyridin-3,5-dicarbonsäure-methyl-(2,2,2-trifluorethyl)-ester, 1,4-dihydro-2,6-dimethyl-4- (2-chlorophenyl) pyridine-3,5-dicarboxylic acid methyl (2,2,2-trifluoroethyl) ester,
^- (2-Chlorphenyl) -pyridin-3,5-dicarbonsäure-ethy 1- (2,2,2-tr if luorethyl) -ester,^ - (2-Chlorophenyl) -pyridine-3,5-dicarboxylic acid-ethy 1- (2,2,2-tr if luoroethyl) ester,
1,4-Dihydro-2,6-dimethyl-4-(2-cyanophenyl)-pyridin-3,5-dicarbonsäure-ethyl-inethyl-ester, 1,4-dihydro-2,6-dimethyl-4- (2-cyanophenyl) -pyridine-3,5-dicarboxylic acid ethyl-methyl-ester,
1,4-Dihydro-2,6-dimethyl-4-(pyridyl-3)-pyridin-3,5-dicarbonsäure-ethyl-methyl-ester, 1,4-dihydro-2,6-dimethyl-4- (pyridyl-3) -pyridine-3,5-dicarboxylic acid ethyl methyl ester,
^- (pyridyl-2) -pyridin-2,5-dicarbonsäure-cyclohexyl-methyl-ester, ^ - (pyridyl-2) -pyridine-2,5-dicarboxylic acid-cyclohexyl-methyl-ester,
-j f 4-Dihydro-2,6-dimethyl-4- (2,1, 3-benzoxadiazolyl-4) pyridin-3,5-dicarbonsäure-isopropyl-methyl-ester, -j f 4-dihydro-2,6-dimethyl-4- (2,1, 3-benzoxadiazolyl-4) pyridine-3,5-dicarboxylic acid isopropyl methyl ester,
1,4-Dihydro-2,6-dimethyl-4-(2,1,3-benzoxadiazolyl-4)-pyridin-3,5-dicarbonsäure-ethyl-methyl-ester, 1,4-dihydro-2,6-dimethyl-4- (2,1,3-benzoxadiazolyl-4) -pyridine-3,5-dicarboxylic acid ethyl methyl ester,
1,4-Dihydro-i,2,6-trimethyl-4-(2,1,3-benzoxadiazolyl-4) pyridin-3,5-dicarbonsäure-isopropyl-methyl-ester,1,4-dihydro-i, 2,6-trimethyl-4- (2,1,3-benzoxadiazolyl-4) pyridine-3,5-dicarboxylic acid isopropyl methyl ester,
1,4-Dihydro-1,2,6-trimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure-ethyl-inethyl-ester, 1,4-dihydro-1,2,6-trimethyl-4- (3-nitrophenyl) -pyridine-3,5-dicarboxylic acid ethyl-methyl-ester,
Le A 23 151Le A 23 151
1,4-Dihydro-1,2,6-trimethyl-4-(2-nitrophenyl)-pyridin-3,5-dicarbonsäure-isobutyl-methyl-ester. 1,4-Dihydro-1,2,6-trimethyl-4- (2-nitrophenyl) -pyridine-3,5-dicarboxylic acid, isobutyl-methyl-ester.
Le A 23 151Le A 23 151
Herstellungsbeispiele Beispiel 1Manufacturing examples example 1
(-) 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure-ethyl-methyl-ester (-) 1,4-Dihydro-2,6-dimethyl-4- (3-nitrophenyl) -pyridine-3,5-dicarboxylic acid ethyl methyl ester
HsC2O2 C yA^ CO2 CH3 HsC 2 O 2 C yA ^ CO 2 CH 3
Zu einer Lösung von 10 g (43,8 mMol) (S)-3-/T2-Methoxymethylpyrrolidin-1-yl)-imino7-buttersäuremethylester in 90 ml absolutem Tetrahydrofuran wurden nach Zugabe von 25 ml Tetramethylethylendxamin bei -700C und unter Stickstoff 28 ml (44,8 mMol) einer 1,6 molaren BuLi-Lösung in η-Hexan zugetropft. Anschließend wurde bei -700C eine Lösung von 11,5 g (43,8 mMol) 2-(3-Nitrobenzyliden)-acetessig-säureethylester in 75 ml Tetrahydrofuran zugetropft. Nach einstündigem Rühren bei -700C wurde das Kühlbad entfernt, die Reaktionslösung bis zum Erreichen von Zimmertemperatur sich selbst überlassen (ca. 3 bis 4 Stunden) und anschließend vorsichtig in Ether/Wasser gegossen. Die wäßrige Phase wurde erneut mit Ether extrahiert und die vereinigten etherischen Extrakte nach Trocknen über wasserfreiem Natriumsulfat im Vakuum eingeengt, wobei ein öliger Rückstand (15 g, M =491) resultierte, der chromatographisch ge-To a solution of 10 g (43.8 mmol) of (S) -3- / T2-Methoxymethyl-pyrrolidin-1-yl) -imino7-methyl butyrate in 90 ml of absolute tetrahydrofuran were added after the addition of 25 ml Tetramethylethylendxamin at -70 0 C and under 28 ml (44.8 mmol) of a 1.6 molar BuLi solution in η-hexane were added dropwise to nitrogen. A solution of 11.5 g (43.8 mmol) was then 2- (3-nitrobenzylidene) -acetessig acid ethyl ester are added dropwise in 75 ml of tetrahydrofuran at -70 0 C. After stirring at -70 0 C, the cooling bath was removed, the reaction solution is left to reach room temperature by itself (about 3 to 4 hours) and then carefully poured into ether / water. The aqueous phase was extracted again with ether and, after drying over anhydrous sodium sulfate, the combined ethereal extracts were concentrated in vacuo, an oily residue (15 g, M = 491) resulting, which was chromatographically
Le A 23 151Le A 23 151
-SG-SG
reinigt wurde. 12g (24 mMol) dieses Zwischenproduktes wurden in 50 ml Methanol aufgenommen und nach Zugabe von 3,2 g (60 mMol) Ammoniumchlorid 15 Stunden zum Sieden erhitzt. Anschließend wurde das Lösungsmittel im Vakuum abdestilliert, der Rückstand in Dichlormethan aufgenommen und mit Wasser gewaschen. Die organische Phase wurde nach Trocknen über NaSO. eingeengt. Das rückbleibende öl kristallisierte nach Verreiben mit Ether teilweise durch, das Rohprodukt wurde abgesaugt, mit Ether gewaschen und getrocknet, 3,3 g (38 %) Fp: 159°C.was cleaned. 12g (24mmol) of this intermediate were taken up in 50 ml of methanol and after adding 3.2 g (60 mmol) of ammonium chloride for 15 hours Boiling heated. The solvent was then distilled off in vacuo, the residue in dichloromethane taken up and washed with water. After drying over NaSO. constricted. That residual oil partially crystallized after trituration with ether, the crude product was filtered off with suction, washed with ether and dried, 3.3 g (38%) mp: 159 ° C.
= -14,97° (C = 0,57 %, Ethanol). = -14.97 ° (C = 0.57%, ethanol).
NO2 NO 2
Analog Beispiel 1 wurde unter Verwendung des (R)-3-/72-Methoxymethylpyrrolidin-i-yl)-imino7-buttersäuremethylesters der rechsdrehende 1,4-Dihyäro-2,6-dimethyl-4-(3-nitrophenyl) -pyridin-3,5-dicarbonsäure-ethyl-methylester erhalten.Analogously to Example 1, using the (R) -3- / 72-methoxymethylpyrrolidin-i-yl) -imino7-butyric acid methyl ester the clockwise 1,4-dihyäro-2,6-dimethyl-4- (3-nitrophenyl) -pyridine-3,5-dicarboxylic acid ethyl methyl ester obtain.
Fp: 160°C,Mp: 160 ° C,
= +15,56 (C = 0,41 %, Ethanol) = +15.56 (C = 0.41%, ethanol)
Le A 23 151Le A 23 151
(-) 1 ^-Dihydro-^fe-cLimethyl-'l- (3-nitrophenyl) -pyridin-3,5-dicarbonsäure-isopropyl-methyl-ester (-) 1 ^ -Dihydro- ^ fe-cLimethyl-'l- (3-nitrophenyl) -pyridine-3,5-dicarboxylic acid -isopropyl-methyl-ester
,.NO2 , .NO 2
O2CvJ^CO2CH3 O 2 C v J ^ CO 2 CH 3
H3C N CH3 H 3 CN CH 3
H
Zu einer Lösung von 7,1 g (31 mMol) (S)-3-/T2-Methoxymethylpyrrolidin-1-yl)-imino7-buttersäuremethylester
in 60 ml absolutem Tetrahydrofuran wurden nach Zugabe von 20 ml Tetramethy!ethylendiamin bei -700C und unter Stickstoff
20 ml (32 mMol) einer 1,6 molaren Lösung von Butyllithium in η-Hexan zugetropft. Anschließend wurde bei -700C
eine Lösung von 8,6 g (31 mMol) 2-(3-Nitrobenzyliden)-acetessigsäureisopropylester
in 40 ml Tetrahydrofuran zugetropft. Die Reaktionsmischung wurde 1 Stunde bei -700C gerührt, anschließend wurde das Kühlbad entfernt
und nach Erreichen von Zimmertemperatur (ca. 3 bis 4 Stunden) wurde die Lösung langsam in Ether/Wasser
gegossen. Die wäßrige Phase wurde mehrmals mit Ether extrahiert und die vereinigten organischen Extrakte
über wasserfreiem Natriumsulfat getrocknet. Verdampfen des Lösungsmittels unter Vakuum lieferte ein öligesH
To a solution of 7.1 g (31 mmol) of (S) -3- / T2-Methoxymethyl-pyrrolidin-1-yl) -imino7-methyl butyrate in 60 ml of absolute tetrahydrofuran were added after addition of 20 ml tetramethyl ethylene diamine at -70 0 C. and 20 ml (32 mmol) of a 1.6 molar solution of butyllithium in η-hexane are added dropwise under nitrogen. A solution of 8.6 g (31 mmol) was then 2- (3-nitrobenzylidene) was added dropwise -acetessigsäureisopropylester in 40 ml of tetrahydrofuran at -70 0 C. The reaction mixture was stirred for 1 hour at -70 0 C, then the cooling bath was removed, and after reaching room temperature (approximately 3 to 4 hours) the solution was poured slowly into ether / water. The aqueous phase was extracted several times with ether and the combined organic extracts were dried over anhydrous sodium sulfate. Evaporation of the solvent in vacuo gave an oily one
Zwischenprodukt (12 g, M = 505), das chromatographisch gereinigt wurde. 8g (15,8 mMol) dieser Verbindung wurden in 50 ml Methanol gelöst und nachIntermediate product (12 g, M = 505) which was purified by chromatography. 8g (15.8mmol) of this Compound were dissolved in 50 ml of methanol and after
Le A 23 151Le A 23 151
- "."jig.- "." jig.
Zugabe von 3,4 g (64 mMol) Ammoniumchlorid 16 Stunden nach Rückfluß erhitzt. Das Lösungsmittel wurde im Vakuum abdestilliert, der Rückstand in Dichlormethan aufgenommen und mit Wasser gewaschen. Die organische Phase wurde über wasserfreiem Natriumsulfat getrocknet, unter Vakuum eingeengt und der ölige Rückstand durch Verreiben mit wenig Ether zur Kristallisation gebracht. Das Festprodukt wurde abgesaugt und getrocknet, 2,3 g (39 %), Fp: 136°CAddition of 3.4 g (64 mmol) ammonium chloride for 16 hours heated to reflux. The solvent was distilled off in vacuo, the residue in dichloromethane taken up and washed with water. The organic phase was dried over anhydrous sodium sulfate, concentrated in vacuo and the oily residue caused to crystallize by trituration with a little ether. The solid product was filtered off with suction and dried, 2.3 g (39%), melting point: 136.degree
CcOJ^ = -24,60° (C = 1,07 %, Ethanol). Beispiel 4 CcOJ ^ = -24.60 ° (C = 1.07%, ethanol). Example 4
NO2 NO 2
°'C ^ J^ ^ CO2CH-° ' C ^ J ^ ^ CO 2 CH-
H3C "Ν CH3
HH 3 C "Ν CH 3
H
Analog Beispiel 3 wurde unter Verwendung des (R)-3-/72-Methoxymethylpyrrolidon-1-yl)-iminoy-buttersäuremethylesters
der rechtsdrehende 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)
-pyridin-^S-dicarbonsäure-isopropyl-methyl-ester
erhalten.
Fp.: 136°CAnalogously to Example 3, using the (R) -3- / 72-methoxymethylpyrrolidon-1-yl) -iminoy-butyric acid methyl ester, the dextrorotatory 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) -pyridine- ^ S-dicarboxylic acid isopropyl methyl ester obtained.
M.p .: 136 ° C
1~°0Jq° = +24,97° (C = 0,93 %, Ethanol). 1 ~ ° 0Jq ° = + 24.97 ° (C = 0.93%, ethanol).
Le A 23 151Le A 23 151
- w --Ä9-- w --Ä9-
(-) 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-pyridin-3,5-dicarbonsäure-isobutyl-methyl-ester (-) 1,4-Dihydro-2,6-dimethyl-4- (2-nitrophenyl) -pyridine-3,5-dicarboxylic acid isobutyl-methyl-ester
H3CH 3 C
H3C N CH3 H 3 CN CH 3
Zu einer Lösung von 7,1 g (31 mMol) (S)-3-/72-Methoxymethylpyrrolidin-1-yl)-iminoy-buttersauremethylester in 60 ml absolutem Tetrahydrofuran wurden nach Zugabe von 20 ml Tetramethylethylendiamin bei -700C und unter Stickstoff 20 ml (32 mMol) einer 1,6 molaren Lösung von Butyllithium in η-Hexan zugetropft. Anschließend wurde bei -700C eine Lösung von 9g (31 mMol) 2-(2-Nitrobenzyliden)-acetessigsäureisobutylester in 50 ml Tetrahydrofuran zugetropft und die Lösung noch 1 Stunde bei -700C gerührt. Das Kühlbad wurde entfernt und nach ErreichenTo a solution of 7.1 g (31 mmol) of (S) -3- / 72-Methoxymethyl-pyrrolidin-1-yl) -iminoy-buttersauremethylester in 60 ml of absolute tetrahydrofuran were added after addition of 20 ml of tetramethylethylenediamine at -70 0 C and under 20 ml (32 mmol) of a 1.6 molar solution of butyllithium in η-hexane were added dropwise to nitrogen. A solution of 9 g (31 mmol) was then stored at -70 0 C 2- (2-nitrobenzylidene) -acetessigsäureisobutylester added dropwise in 50 ml of tetrahydrofuran and the solution stirred for a further 1 hour at -70 0C. The cooling bath was removed and upon reaching
-j5 von Zimmertemperatur (ca. 3 bis 4 Stunden) wurde die Lösung langsam in Ether/Wasser gegossen. Die wäßrige Phase wurde nochmals mit Ether extrahiert und die vereinigten organischen Extrakte über wasserfreiem Natriumsulfat getrocknet. Abdestillieren des Lösungsmittels unter Vakuum ergab ein öliges Zwischenprodukt (12,8 g, M = /519), das chromatographisch über Kieselgel gereinigt wurde.-j5 from room temperature (about 3 to 4 hours) was the Solution slowly poured into ether / water. The aqueous phase was extracted again with ether and the combined organic extracts dried over anhydrous sodium sulfate. Distilling off the solvent under vacuum gave an oily intermediate (12.8 g, M = / 519) which was chromatographed on Silica gel has been purified.
Le A 23 151Le A 23 151
6,4 g (12,3 mMol) dieser Verbindung wurden in 25 ml Methanol gelöst und nach Zugabe von 1,61 g (30,2 mMol) Ammoniumchlorid 15 Stunden unter Rückfluß erhitzt. Das Lösungsmittel wurde im Vakuum abdestilliert, der Rückstand in Dichlormethan aufgenommen und mit Wasser gewaschen. Die organische Phase wurde über wasserfreiem Natriumsulfat getrocknet, unter Vakuum eingeengt und der ölige Rückstand chromatographisch gereinigt, 1,4 g (30 %) amorphes Produkt.6.4 g (12.3 mmol) of this compound were in 25 ml Dissolved methanol and, after the addition of 1.61 g (30.2 mmol) of ammonium chloride, heated under reflux for 15 hours. The solvent was distilled off in vacuo, the residue was taken up in dichloromethane and washed with water washed. The organic phase was dried over anhydrous sodium sulfate, concentrated in vacuo and the oily residue is purified by chromatography, 1.4 g (30%) of amorphous product.
= -I66'40 <0'49 % w/v. Ethanol). = -I 66 '40' 0 '49% w / v. Ethanol).
H3CH 3 C
H3CH 3 C
HC-H2CO2CHC-H 2 CO 2 C
H3CH 3 C
CH3 CH 3
Analog Beispiel 5 wurde unter Verwendung des (R)-3-/72-Methoxymethylpyrrolidin-1-yl)-iminoy-buttersäuremethylesters der rechtsdrehende 1,4-Dihydro-2,6-dime thyl-4-(2-nitrophenyl)-pyridin-3,5-dicarbonsäure-isobutyl-methylester erhalten.Analogously to Example 5, using the (R) -3- / 72-methoxymethylpyrrolidin-1-yl) -iminoy-butyric acid methyl ester the dextrorotatory 1,4-dihydro-2,6-dimethyl-4- (2-nitrophenyl) -pyridine-3,5-dicarboxylic acid-isobutyl-methyl ester obtain.
= +166,3° (0,68 % w/v, Ethanol). = + 166.3 ° (0.68% w / v, ethanol).
Le A 23 151Le A 23 151
Claims (9)
R und R immer verschieden sind und für einen achiralen geradkettigen, verzweigten oder cyclischen/ gesättigten oder ungesättigten Kohlenwasserstoffrest stehen, der gegebenenfalls durch ein Sauerstoff- oder Schwefelatom in der5
R and R are always different and represent an achiral straight-chain, branched or cyclic / saturated or unsaturated hydrocarbon radical, which is optionally replaced by an oxygen or sulfur atom in the
R und R , gleich oder verschieden sein können, für Wasserstoff oder vorzugsweise für einen geradkettigen oder verzweigten, gegebenenfalls substituierten Alkylrest mit bis zu 4 Kohlenstoffatomen, einen Phenyl oder einen Benzyl-2 4
R and R, can be identical or different, for hydrogen or preferably for a straight-chain or branched, optionally substituted alkyl radical with up to 4 carbon atoms, a phenyl or a benzyl
I* R.
I *
■J5 R und R , gleich oder verschieden sein können, für Wasserstoff oder vorzugsweise für einen geradkettigen oder verzweigten, gegebenenfalls stituierten Alkylrest mit bis zu 4 Kohlenstoffatomen, einen Phenyl oder einen Benzylrest,4th
■ J5 R and R, can be identical or different, for hydrogen or preferably for a straight-chain or branched, optionally substituted alkyl radical with up to 4 carbon atoms, a phenyl or a benzyl radical,
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843423105 DE3423105A1 (en) | 1984-06-22 | 1984-06-22 | METHOD FOR PRODUCING OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE |
| US06/741,099 US4703119A (en) | 1984-06-22 | 1985-06-04 | Intermediates of optically active 1,4-dihydropyridines |
| EP85107174A EP0166296B1 (en) | 1984-06-22 | 1985-06-11 | Process for the preparation of optically active 1,4-dihydropyridines |
| AT85107174T ATE37873T1 (en) | 1984-06-22 | 1985-06-11 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,4DIHYDROPYRIDINE. |
| DE8585107174T DE3565535D1 (en) | 1984-06-22 | 1985-06-11 | Process for the preparation of optically active 1,4-dihydropyridines |
| JP60133149A JPH0635438B2 (en) | 1984-06-22 | 1985-06-20 | Process for producing optically active 1,4-dihydropyridines |
| JP5114159A JPH0641063A (en) | 1984-06-22 | 1993-04-19 | Pyrrolidine derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843423105 DE3423105A1 (en) | 1984-06-22 | 1984-06-22 | METHOD FOR PRODUCING OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3423105A1 true DE3423105A1 (en) | 1986-01-02 |
Family
ID=6238924
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19843423105 Withdrawn DE3423105A1 (en) | 1984-06-22 | 1984-06-22 | METHOD FOR PRODUCING OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE |
| DE8585107174T Expired DE3565535D1 (en) | 1984-06-22 | 1985-06-11 | Process for the preparation of optically active 1,4-dihydropyridines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8585107174T Expired DE3565535D1 (en) | 1984-06-22 | 1985-06-11 | Process for the preparation of optically active 1,4-dihydropyridines |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4703119A (en) |
| EP (1) | EP0166296B1 (en) |
| JP (2) | JPH0635438B2 (en) |
| AT (1) | ATE37873T1 (en) |
| DE (2) | DE3423105A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
| EP0287828A1 (en) * | 1987-03-27 | 1988-10-26 | Byk Gulden Lomberg Chemische Fabrik GmbH | Intermediates and their preparation |
| AU1541188A (en) * | 1987-03-27 | 1988-11-02 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New optically active compounds |
| ATE234286T1 (en) * | 1993-12-10 | 2003-03-15 | Bayer Ag | PHENYL-SUBSTITUTED 1,4-DIHYDROPYRIDINES WITH CEREBRAL ACTIVITY |
| DE4443168A1 (en) * | 1994-12-05 | 1996-06-13 | Bayer Ag | New highly selective process for the production of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2935451A1 (en) * | 1979-09-01 | 1981-03-19 | Bayer Ag, 5090 Leverkusen | OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT |
-
1984
- 1984-06-22 DE DE19843423105 patent/DE3423105A1/en not_active Withdrawn
-
1985
- 1985-06-04 US US06/741,099 patent/US4703119A/en not_active Expired - Fee Related
- 1985-06-11 DE DE8585107174T patent/DE3565535D1/en not_active Expired
- 1985-06-11 EP EP85107174A patent/EP0166296B1/en not_active Expired
- 1985-06-11 AT AT85107174T patent/ATE37873T1/en not_active IP Right Cessation
- 1985-06-20 JP JP60133149A patent/JPH0635438B2/en not_active Expired - Lifetime
-
1993
- 1993-04-19 JP JP5114159A patent/JPH0641063A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0635438B2 (en) | 1994-05-11 |
| EP0166296A2 (en) | 1986-01-02 |
| DE3565535D1 (en) | 1988-11-17 |
| US4703119A (en) | 1987-10-27 |
| JPH0641063A (en) | 1994-02-15 |
| EP0166296A3 (en) | 1987-05-27 |
| JPS6112663A (en) | 1986-01-21 |
| ATE37873T1 (en) | 1988-10-15 |
| EP0166296B1 (en) | 1988-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0088276B1 (en) | Compounds, process for their preparation and their use as pharmaceutical preparations | |
| EP0011706B1 (en) | Process for the preparation of derivatives of 1,4-dihydropyridine-3-carboxylic acid, derivatives of 1,4-dihydropyridine-3-carboxylic acid and the use of these derivatives for the preparation of 1,4-dihydropyridine-3,5-dicarboxylates | |
| EP0088274B1 (en) | 1,4-dihydropyridines, process for their preparation and their application as pharmaceutical preparations | |
| EP0026317A1 (en) | Optically active 1,4-dihydropyridines, processes for their preparation and their use as medicaments | |
| EP0002208A1 (en) | Nitro 1,4-dihydropyridines, medicaments containing them and their manufacture | |
| EP0012180A1 (en) | 1,4-Dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions | |
| EP0001769A1 (en) | Sulfur-containing esters of 1,4-dihydropyridine carboxylic acids, their preparation and pharmaceutical use | |
| DE2841667A1 (en) | FLUORINE 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT | |
| EP0088940B1 (en) | Pyridine-carboxylic-acid esters, process for their preparation and their use as pharmaceutical compositions | |
| DE3209276A1 (en) | MEDICINAL PRODUCTS WITH ANTI-HYPOXIC AND ISCHAEMY-PROTECTIVE EFFECT | |
| EP0039863B1 (en) | 1,4-dihydropyridines with different substituents in positions 2 and 6, processes for their preparation and their use in medicines | |
| DE3042769A1 (en) | C-3 LINKED 1,4-DIHYDROPYRIDINE, THEIR USE IN MEDICINAL PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF | |
| EP0110259B1 (en) | 1,4-dihydropyridines, processes for their preparation and their use in medicines | |
| DE2658804A1 (en) | Compsn. with circulatory and cardiac activity - contains a 3-cyano-1,2-di:hydro-pyridine deriv. | |
| DE3130041A1 (en) | Dihydropyridines having a positive inotropic effect, novel compounds, their use in medicaments, and processes for their preparation | |
| EP0166296B1 (en) | Process for the preparation of optically active 1,4-dihydropyridines | |
| EP0157324A2 (en) | Tetrahydrothienopyridines, process for their preparation and their pharmaceutical application | |
| DE2847237A1 (en) | Cardiovascular 1,4-di:hydro-pyridine-3-carboxylic acids prodn. - by alkaline hydrolysis of ester(s) with electron withdrawing substit. | |
| DE2639498A1 (en) | NEW SULFUR-CONTAINING AMINO-DIHYDROPYRIDINES, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT | |
| CH633265A5 (en) | METHOD FOR PRODUCING THE NEW 1.4-DIHYDRO-2.6-DIMETHYL-4- (3-NITROPHENYL) -3.5-PYRIDINDICARBONIC ACID ISOPROPYL- (2-PROPOXY-AETHYL) ESTER. | |
| DE2616991A1 (en) | Thio-substd. dihydro-pyridine derivs. - coronary vasodilators and antihypertensives prepd. e.g. by reacting dicarbonyl cpds. with amines and thio-substd. ketones | |
| EP0225574B1 (en) | Novel 1,4-dihydropyridines containing fluorine, process for their preparation and their use as medicaments | |
| EP0347678B1 (en) | 1,4-Dihydropyridine threonin derivatives and process for their preparation | |
| EP0167068B1 (en) | Isopropyl-2[2-(3-trifluoromethylphenoxy)ethyl]ester of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylic acid, process for its preparation, and its use as a medicine | |
| DE2921429A1 (en) | 3-Carboxy-1,4-di:hydro-pyridine derivs. prodn. - by hydrolysing substd. ester, useful as cardiovascular agents and intermediates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8130 | Withdrawal |